|
Originally published In Press as doi:10.1074/jbc.M207127200 on August 6, 2002
J. Biol. Chem., Vol. 277, Issue 42, 39274-39279, October 18, 2002
Regulation of the EphA2 Kinase by the Low Molecular Weight
Tyrosine Phosphatase Induces Transformation*
Keith D.
Kikawa ,
Derika R.
Vidale§,
Robert L.
Van Etten§, and
Michael S.
Kinch ¶
From the Departments of Basic Medical Sciences and
§ Chemistry, Purdue University, West Lafayette, Indiana
47907 and ¶ MedImmune, Inc.,
Gaithersburg, Maryland 20878
Intracellular signaling by protein tyrosine
phosphorylation is generally understood to govern many aspects of
cellular behavior. The biological consequences of this signaling
pathway are important because the levels of protein tyrosine
phosphorylation are frequently elevated in cancer cells. In the classic
paradigm, tyrosine kinases promote tumor cell growth, survival, and
invasiveness, whereas tyrosine phosphatases negatively regulate these
same behaviors. Here, we identify one particular tyrosine
phosphatase, low molecular weight tyrosine phosphatase (LMW-PTP), which
is frequently overexpressed in transformed cells. We also show that
overexpression of LMW-PTP is sufficient to confer transformation upon
non-transformed epithelial cells. Notably, we show that the EphA2
receptor tyrosine kinase is a prominent substrate for LMW-PTP and that
the oncogenic activities of LMW-PTP result from altered EphA2
expression and function. These results suggest a role for LMW-PTP in
transformation progression and link its oncogenic potential to EphA2.
*
This work was supported by from National Institutes
of Health Grants 1 U01 CA91318 (to M. K.) and GM27003 (to R. V. E.)
and by grants from the Department of Defense Breast and Prostate Cancer Research Programs.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: MedImmune, Inc.,
35 West Watkins Mill Rd., Gaithersburg, MD 20878. Tel.: 240-632-4639; Fax: 301-527-4200; E-mail: kinchm@medimmune.com.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Wykosky and W. Debinski
The EphA2 Receptor and EphrinA1 Ligand in Solid Tumors: Function and Therapeutic Targeting
Mol. Cancer Res.,
December 1, 2008;
6(12):
1795 - 1806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. D. Stoner, A. A. Dombkowski, R. K. Reen, D. Cukovic, S. Salagrama, L.-S. Wang, and J. F. Lechner
Carcinogen-Altered Genes in Rat Esophagus Positively Modulated to Normal Levels of Expression by Both Black Raspberries and Phenylethyl Isothiocyanate
Cancer Res.,
August 1, 2008;
68(15):
6460 - 6467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Wimmer-Kleikamp, E. Nievergall, K. Gegenbauer, S. Adikari, M. Mansour, T. Yeadon, A. W. Boyd, N. R. Patani, and M. Lackmann
Elevated protein tyrosine phosphatase activity provokes Eph/ephrin-facilitated adhesion of pre-B leukemia cells
Blood,
August 1, 2008;
112(3):
721 - 732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. B. Fang, D. M. Brantley-Sieders, Y. Hwang, A.-J. L. Ham, and J. Chen
Identification and Functional Analysis of Phosphorylated Tyrosine Residues within EphA2 Receptor Tyrosine Kinase
J. Biol. Chem.,
June 6, 2008;
283(23):
16017 - 16026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lackmann and A. W. Boyd
Eph, a Protein Family Coming of Age: More Confusion, Insight, or Complexity?
Sci. Signal.,
April 15, 2008;
1(15):
re2 - re2.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. B. Fang, R. C. Ireton, G. Zhuang, T. Takahashi, A. Reynolds, and J. Chen
Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism
J. Cell Sci.,
February 1, 2008;
121(3):
358 - 368.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Mancini, S. Rigacci, A. Berti, C. Balduini, and M. Torti
The low-molecular-weight phosphotyrosine phosphatase is a negative regulator of Fc{gamma}RIIA-mediated cell activation
Blood,
September 15, 2007;
110(6):
1871 - 1878.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. K. Noren and E. B. Pasquale
Paradoxes of the EphB4 Receptor in Cancer
Cancer Res.,
May 1, 2007;
67(9):
3994 - 3997.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kanda, Y. Ihara, H. Murata, Y. Urata, T. Kono, J. Yodoi, S. Seto, K. Yano, and T. Kondo
Glutaredoxin Modulates Platelet-derived Growth Factor-dependent Cell Signaling by Regulating the Redox Status of Low Molecular Weight Protein-tyrosine Phosphatase
J. Biol. Chem.,
September 29, 2006;
281(39):
28518 - 28528.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. R. Zabell, A. D. Schroff Jr., B. E. Bain, R. L. Van Etten, O. Wiest, and C. V. Stauffacher
Crystal Structure of the Human B-form Low Molecular Weight Phosphotyrosyl Phosphatase at 1.6-A Resolution
J. Biol. Chem.,
March 10, 2006;
281(10):
6520 - 6527.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Parri, F. Buricchi, M. L. Taddei, E. Giannoni, G. Raugei, G. Ramponi, and P. Chiarugi
EphrinA1 Repulsive Response Is Regulated by an EphA2 Tyrosine Phosphatase
J. Biol. Chem.,
October 7, 2005;
280(40):
34008 - 34018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Xu, W. Tian, J. N. Lindsley, T. T. Oyama, J. M. Capasso, C. J. Rivard, H. T. Cohen, S. M. Bagnasco, S. Anderson, and D. M. Cohen
EphA2: expression in the renal medulla and regulation by hypertonicity and urea stress in vitro and in vivo
Am J Physiol Renal Physiol,
April 1, 2005;
288(4):
F855 - F866.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Herrem, T. Tatsumi, K. S. Olson, K. Shirai, J. H. Finke, R. M. Bukowski, M. Zhou, A. L. Richmond, I. Derweesh, M. S. Kinch, et al.
Expression of EphA2 is Prognostic of Disease-Free Interval and Overall Survival in Surgically Treated Patients with Renal Cell Carcinoma
Clin. Cancer Res.,
January 1, 2005;
11(1):
226 - 231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hu, K. L. Carles-Kinch, D. P. Zelinski, and M. S. Kinch
EphA2 Induction of Fibronectin Creates a Permissive Microenvironment for Malignant Cells
Mol. Cancer Res.,
October 1, 2004;
2(10):
533 - 540.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. H. Thaker, M. Deavers, J. Celestino, A. Thornton, M. S. Fletcher, C. N. Landen, M. S. Kinch, P. A. Kiener, and A. K. Sood
EphA2 Expression Is Associated with Aggressive Features in Ovarian Carcinoma
Clin. Cancer Res.,
August 1, 2004;
10(15):
5145 - 5150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Walker-Daniels, A. R. Hess, M. J.C. Hendrix, and M. S. Kinch
Differential Regulation of EphA2 in Normal and Malignant Cells
Am. J. Pathol.,
April 1, 2003;
162(4):
1037 - 1042.
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|